EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design

Wiktor Tomasz Gawełczyk, James Chmiel, Jerzy Leszek

Pharmacotherapy in Psychiatry and Neurology · 2026

DOI: 10.17219/fpn/242038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2026. Verfasst von Wiktor Tomasz Gawełczyk und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gawełczyk, W. T., Chmiel, J., & Leszek, J. (2026). Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design. Pharmacotherapy in Psychiatry and Neurology. https://doi.org/10.17219/fpn/242038

Vancouver

Gawełczyk WT, Chmiel J, Leszek J. Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design. Pharmacotherapy in Psychiatry and Neurology. 2026. doi:10.17219/fpn/242038

BibTeX
@article{Gaweczyk2026,
  author = {Gawełczyk, Wiktor Tomasz and Chmiel, James and Leszek, Jerzy},
  title = {Vaccines against Alzheimer’s disease: Clinical trial evidence, safety and endpoint design},
  journal = {Pharmacotherapy in Psychiatry and Neurology},
  year = {2026},
  doi = {10.17219/fpn/242038}
}
Kostenlos starten →